江蘇國信(002608.SZ):江蘇信託2020年度擬使用自有資金購買信託計劃 額度不超90億元
格隆匯12月4日丨江蘇國信(002608.SZ)公佈,公司之控股子公司江蘇省國際信託有限責任公司(“江蘇信託”)為提高資金使用效率,提升存量資金收益,在保障日常運營資金需求的前提下,2020年度擬使用自有資金購買信託計劃,額度不超過人民幣90億元,並授權公司管理層具體實施相關事宜。在上述額度內,資金可滾動使用。信託計劃屬於金融產品投資,金融產品投資是江蘇信託經中國銀監會核准的業務之一。江蘇信託以自有資金投資信託計劃可以提高資金使用效率,增加投資收益,拓展盈利渠道,不會影響其信託業務的發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.